1-(4-fluorophenyl)-N-[(1S)-1-(5-methylsulfanyl-1H-pyrrol-2-yl)ethyl]pyrazolo[5,4-c]pyridine-4-carboxamide
C20H18FN5OS — CID 141264520
Data last refreshed: (MolForge compound catalog, from PubChem)
About 1-(4-fluorophenyl)-N-[(1S)-1-(5-methylsulfanyl-1H-pyrrol-2-yl)ethyl]pyrazolo[5,4-c]pyridine-4-carboxamide
1-(4-fluorophenyl)-N-[(1S)-1-(5-methylsulfanyl-1H-pyrrol-2-yl)ethyl]pyrazolo[5,4-c]pyridine-4-carboxamide (PubChem CID 141264520) has the molecular formula C20H18FN5OS and a molecular weight of 395.46 g/mol. Its IUPAC name is 1-(4-fluorophenyl)-N-[(1S)-1-(5-methylsulfanyl-1H-pyrrol-2-yl)ethyl]pyrazolo[5,4-c]pyridine-4-carboxamide.
Molecular Properties
| Compound Name | 1-(4-fluorophenyl)-N-[(1S)-1-(5-methylsulfanyl-1H-pyrrol-2-yl)ethyl]pyrazolo[5,4-c]pyridine-4-carboxamide |
|---|---|
| PubChem CID | 141264520 |
| Molecular Formula | C20H18FN5OS |
| Molecular Weight | 395.46 g/mol |
| Exact Mass | 395.12 |
| IUPAC Name | 1-(4-fluorophenyl)-N-[(1S)-1-(5-methylsulfanyl-1H-pyrrol-2-yl)ethyl]pyrazolo[5,4-c]pyridine-4-carboxamide |
| SMILES | CSc1ccc([C@H](C)NC(=O)c2cncc3c2cnn3-c2ccc(F)cc2)[nH]1 |
| InChI | InChI=1S/C20H18FN5OS/c1-12(17-7-8-19(25-17)28-2)24-20(27)16-9-22-11-18-15(16)10-23-26(18)14-5-3-13(21)4-6-14/h3-12,25H,1-2H3,(H,24,27)/t12-/m0/s1 |
| InChIKey | SBIROJHLQQRXTH-LBPRGKRZSA-N |
| XLogP | 4.10 |
| TPSA | 75.60 Ų |
| H-Bond Donors | 2 |
| H-Bond Acceptors | 5 |
| Rotatable Bonds | 5 |
| Heavy Atoms | 28 |
| Complexity | — |
Lipinski Rule of Five
Passes Rule of Five
| Rule | Value |
|---|---|
| MW ≤ 500 | 395.46 |
| LogP ≤ 5 | 4.10 |
| H-Bond Donors ≤ 5 | 2 |
| H-Bond Acceptors ≤ 10 | 5 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 141264520 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.